STAAR Surgical (STAA)

• Market cap: $1.22B
• 1 day: -0.64%
• 5 days: 1.22%
• 1 month: -5.70%
• 3 months: -18.33%
• 6 months: -38.12%
• Year to date: -16.52%
• 1 year: -19.88%
• 5 years: -31.81%
• 10 years: 166.31%
• Sector: Healthcare
• Industry: Ophthalmic Goods

About: Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.

Employees: 1,115

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

95% more call options, than puts

Call options by funds: $17.7M | Put options by funds: $9.05M

41% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 32

20% more funds holding in top 10

Funds holding in top 10: 5 [Q2] → 6 (+1) [Q3]

6% more funds holding

Funds holding: 218 [Q2] → 231 (+13) [Q3]

0.03% less ownership

Funds ownership: 97.52% [Q2] → 97.49% (-0.03%) [Q3]

9% less repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 79

22% less capital invested

Capital invested by funds: $2.28B [Q2] → $1.78B (-$499M) [Q3]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $28 13% upside
• Avg. target: $28 13% upside
• High target: $28 13% upside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

Canaccord Genuity Jon Young 50% 1-year accuracy 3 / 6 met price target

13% upside $28

Hold Maintained

9 Dec 2024